查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
生物製剂外包市场：按产品类型、按应用、按国家、按地区-行业分析、市场规模、市场份额、2023-2030 年预测
市场调查报告书
商品编码
1290847

生物製剂外包市场：按产品类型、按应用、按国家、按地区-行业分析、市场规模、市场份额、2023-2030 年预测

Biologics Outsourcing Market with COVID-19 Impact Analysis, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 379 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022年生物製剂外包市场规模将达到804.103亿美元，2023年至2030年復合年增长率为18.7%

生物製品外包市场-市场动态

为了经济地利用先进生物製剂的开发和製造能力，生物製药公司的外包趋势不断增加，预计这将推动市场的增长。

生物製药行业外包趋势的日益增长使公司能够以具有成本效益的方式获得先进的生物製剂开发和製造能力。外包使公司能够利用先进的设施、设备和专业知识，而无需进行大量资本投资。CRO（合同研究实验室）和 CMO（合同製造组织）配备了经验丰富的科学家和工程师，具备处理复杂生物製品工艺所需的技能。截至2023年，美国共有合同研究机构2823家，较2022年增长0.9%。根据美国行业统计，CRO行业的运营成本占销售额的比例为工资（29.1%）、采购（6.8%）、租金和水电费（3.4%）。通过利用我们外包合作伙伴的专业知识和基础设施，公司可以优化运营、降低财务风险并加速生物製品商业化。

生物製剂外包市场 - 主要见解

  • 由于可持续增长意识的增强，预计生物製品外包行业将出现显着增长
  • 从产品类型来看，抗体将是2022年的主要类型
  • 从应用来看，2022年治疗药物将成为主要类型。
  • 按地区划分，北美将在 2022 年销量领先。

生物製品外包市场细分分析：

全球生物製品外包市场根据特异性、类型、应用和区域进行细分。

根据产品类型，市场分为五类：抗体、基因工程、蛋白质、疫苗和其他。抗体主导市场。这些是常见的外包类型的生物製剂。抗体是免疫系统响应外来物质（例如病原体或异常细胞）的存在而产生的蛋白质。外包抗体开发和製造为生物製药公司提供了多种优势。

市场按应用分为三类：治疗、诊断和研究。治疗药物在市场上占据主导地位，并将在预测期内保持其主导地位。外包生物製剂用于治疗，通常用于治疗癌症、自身免疫性疾病和遗传性疾病等复杂疾病。生物製剂外包市场是指与生物製剂和治疗药物的开发、製造和商业化相关的各种流程的外包。

生物製剂外包市场 - 地理洞察

从地理上看，该市场遍布北美、拉丁美洲、欧洲、亚太地区、中东和非洲。这些区域根据我们开展业务的国家/地区进一步细分。由于生物製药公司研发支出增加以及生物类似药的批准和推广增加，预计生物製品外包市场将由北美主导。北美生物製药公司投入大量资源进行研发活动。我们对研究和开发的关注促进了创新生物製剂和疗法的开发。美国药物研究与製造商协会预测，美国生物製药行业在新药开发方面处于世界领先地位，PhRMA成员公司继续走在前列。2020年美国生物製药研发投资总额预计为1220亿美元。由于细胞系工程（基因编辑工具）和细胞系开发技术的技术进步，预计欧洲和亚太地区将推动生物製剂外包市场的显着增长。

生物製剂外包市场 - 竞争格局：

公司在研发方面投入巨资，以提高细胞系开发技能、开发新产品并探索新颖的治疗应用。生物製剂外包市场竞争激烈，多家公司争夺市场份额。例如，Boehringer Ingelheim将在2023年斥资3.86亿美元在德国开设一家研发工厂。Boehringer Ingelheim表示，生物製剂开发中心（BDC）将开发抗体和治疗性蛋白质，并生产用于临床试验的材料。生物仿製药的增长及其开发和製造的需求也增加了对生物製剂外包的需求。生物仿製药开发商通常依赖外包合作伙伴来利用他们的专业知识和基础设施。

近期动向

2022 年4 月，全球领先的生物製药、细胞、遗传和消费医学合作伙伴能够通过多种方式优化开发、商业化和提供更好的患者治疗方法康泰伦特宣布收购了牛津附近目前正在建设的生物製剂开发和製造工厂，英国，来自英国疫苗、製造和创新中心有限公司（VMIC Ltd.）。

研究的主要特点

  • 这份生物製剂外包市场研究报告提供了以2022年为基准年的市场规模、复合年增长率（CAGR%）、估计和预测（2023-2030年）。
  • 该研究报告为客户提供了有关生物製剂外包市场最新发展的见解。
  • 该研究报告阐明了不同细分市场/国家的潜在增长机会，并说明了生物製品外包市场有吸引力的投资主张矩阵。
  • 总体报告确定了新的投资机会、现有企业面临的挑战以及生物製剂外包市场可持续发展的增长动力。
  • 研究范围详细探讨了COVID-19对生物製品外包市场规模、预测、复合年增长率和市场动态的影响。还涵盖了对后COVID-19生物製品外包市场的深入见解。
  • 为了向本报告的用户提供生物製品外包市场的全面了解，我们还对生物製品外包市场的竞争格局和主要创新者进行了分析。
  • 该研究涵盖了基于市场规模、增长率和吸引力对所有行业领域进行基准测试的增长前景映射分析。
  • 提供主要市场进入者的详细公司概况，以帮助您了解在生物製剂外包市场运营的公司的财务信息和战略举措。
  • 此外，报告还揭示了市场主要进入者不仅在全球层面而且在区域层面的重大收购和兼併、联盟和合资企业、新产品推出、研发和区域扩张。
  • 全球生物製剂外包市场报告主要针对该行业的各个利益相关者，如供应商、投资者、新进入者、分销商和财务分析师。

目录

第一章 生物製剂外包市场概况

  • 调查范围

第二章执行摘要

  • 市场细分
  • 竞争考虑

第三章 生物製剂外包市场主要趋势

  • 生物製剂外包市场驱动因素
  • 生物製剂外包市场製约因素
  • 生物製品外包市场机遇
  • 生物製品外包市场的未来趋势

第四章 生物製品外包行业概况

  • PEST分析
  • 波特五力分析
  • 绘製增长前景
  • 监管框架分析

第五章 生物製品外包市场：COVID-19 的影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后的影响分析

第六章 生物製剂外包市场格局

  • 2022 年生物製品外包市场份额分析
  • 主要製造商的细分数据
    • 已成立公司分析
    • 启动分析

7. 生物製品外包市场——按产品类型

  • 概述
    • 按产品类型划分的细分市场份额分析
    • 抗体
    • 重组
    • 蛋白质
    • 疫苗接种
    • 其他

8. 生物製剂外包市场——按应用

  • 概述
    • 按应用划分的细分市场份额分析
    • 治疗
    • 诊断
    • 研究

9.生物製剂外包市场——按地区

  • 介绍
  • 北美
    • 概述
    • 主要製造商
    • 美国
    • 加拿大
  • 欧洲
    • 概述
    • 主要製造商
    • 德国
    • 意大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 其他
  • 亚太地区 (APAC)
    • 概述
    • 主要製造商
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳大利亚
    • 泰国
    • 印度尼西亚
    • 菲律宾
    • 其他
  • 拉丁美洲
    • 概述
    • 主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他
  • 中东和非洲
    • 概述
    • 主要製造商
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他

第十章主要供应商分析-生物製剂外包行业

  • 比赛仪表板
  • 公司简介
    • Boehringer Ingelheim
    • Catalent
    • GenScript
    • Innovent Biologics
    • Syngene
    • Shanghai Medicilon
    • GL Biochem Corporation
    • GVK Biosciences Private
    • Horizon Discovery Group
    • Selexis
    • Lonza
    • Abzena
    • Adimab

第十一章 分析师的全面看法

Product Code: ANV1293

REPORT HIGHLIGHT

The Biologics Outsourcing Market size was valued at USD 80,410.3 million in 2022, expanding at a CAGR of 18.7% from 2023 to 2030.

Biologics are a more complex class of medicines to manufacture, package, store, and distribute than their chemical counterparts. Outsourcing of any aspect of the supply chain means pharmaceutical companies and their chosen vendors need to work in true partnership, navigating the complex process together to ensure speed to market. Developing and manufacturing biologic drugs in-house can be costly due to the need for specialized facilities, equipment, and personnel. Outsourcing allows companies to avoid or reduce these capital investments and instead pay for specific services or processes as needed, potentially resulting in cost savings.

Biologics Outsourcing Market- Market Dynamics

Increasing trend of outsourcing among biopharma companies to gain economical access to advanced biologics development and manufacturing capacities is expected to propel market growth

The increasing trend of outsourcing in the biopharmaceutical industry enables companies to gain access to advanced biologics development and manufacturing capacities in a cost-effective manner. Outsourcing allows companies to access advanced facilities, equipment, and expertise without the need for substantial capital investments. contract research organizations (CROs)and contract manufacturing organizations (CMOs) are equipped with experienced scientists and technicians who possess the necessary skills to handle complex biologics processes. There are 2,823 Contract Research Organizations businesses in the US as of 2023, an increase of 0.9% from 2022. The highest costs for business in The Contract Research Organizations industry in the US as a percentage of revenue are Wages (29.1%), Purchases (6.8%), and Rent & Utilities (3.4%, according to industry statistics of U.S. By leveraging the expertise and infrastructure of outsourcing partners, companies can optimize their operations, reduce financial risks, and accelerate the commercialization of their biologic products.

Biologics Outsourcing Market- Key Insights

  • As per the analysis shared by our research analyst, the global Biologics outsourcing market is estimated to grow annually at a CAGR of around XX% over the forecast period (2023-2030)
  • The Biologics outsourcing industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
  • Based on product type segmentation, Antibody was the leading type in 2022
  • Based on Application segmentation, Therapeutics was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Biologics Outsourcing Market- Segmentation Analysis:

The Global Biologics Outsourcing Market is segmented on the basis of specificity, Type, Application, and Region.

The market is divided into five categories based on Product Type: Antibody, Recombinant, Protein, Vaccines, and Others. Antibody dominates the market. These are commonly outsourced types of biological products. Antibodies are proteins produced by the immune system in response to the presence of foreign substances, such as pathogens or abnormal cells. Outsourcing the development and manufacturing of antibodies can offer several advantages to biopharmaceutical companies.

The market is divided into three categories based on Application: Therapeutics, Diagnostics, and Research. Therapeutics dominate the market and are likely to maintain their dominance during the forecast period. Biologics Outsources are used for therapeutic purposes, often to treat complex diseases like cancer, autoimmune disorders, or genetic diseases. The biologics outsourcing market refers to the outsourcing of various processes related to the development, manufacturing, and commercialization of biologic drugs or therapeutics.

Biologics Outsourcing Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate Biologics Outsourcing Market, due to increasing R&D spend of biopharma companies and escalating approvals and uptake of biosimilar. Biopharmaceutical companies in North America have been allocating significant resources to research and development activities. This focus on R&D allows them to develop innovative biologic drugs and therapies. Pharmaceutical Research and Manufacturers of America predicted that the U.S. biopharmaceutical industry has been the world leader in the development of new medicines, and PhRMA member companies continue to be at the forefront. The entire U.S. biopharmaceutical invested an estimated USD122 billion in R&D in 2020. Europe and Asia Pacific are expected to propel significant growth in Biologics Outsourcing Market, due to the Technological advancements in cell line engineering (gene editing tools) & cell line development technologies.

Biologics Outsourcing Market- Competitive Landscape:

Companies invest heavily in research and development to enhance their cell line development technologies, develop new products, and explore novel therapeutic applications. These players offer a wide range of services, including contract research, contract manufacturing, clinical trial services, and other support services for biopharmaceutical companies The Biologics outsourcing market is highly competitive, with several companies vying for market share. For instance, in 2023, Boehringer Ingelheim opens a USD386m German R&D plant. The Biologics Development Center (BDC) will develop antibodies and therapeutic proteins and manufacture substances for clinical trials, says Boehringer Ingelheim. The growth of biosimilar and the need for their development and manufacturing are also contributing to the demand for biologics outsourcing. Biosimilar developers often rely on outsourcing partners to leverage their expertise and infrastructure.

Recent Developments:

In April 2022, Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize the development, launch, and supply of better patient treatments across multiple modalities, nowadays announced the acquisition from Vaccine Manufacturing and Innovation Centre UK Limited (VMIC Ltd.) of a biologics development and manufacturing facility currently under construction near Oxford, U.K.

Key features of the study:

  • This proposed research study on Biologics outsourcing market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Biologics outsourcing market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Biologics outsourcing market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Biologics outsourcing market
  • Impact of COVID-19 on Biologics outsourcing market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Biologics outsourcing market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Biologics outsourcing market, we have also included competitive landscape and key innovator analysis for the Biologics outsourcing market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Biologics outsourcing market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Biologics outsourcing market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOLOGICS OUTSOURCING MARKET KEY PLAYERS

  • Boehringer Ingelheim
  • Catalent
  • GenScript
  • Innovent Biologics
  • Syngene
  • Shanghai Medicilon
  • GL Biochem Corporation
  • GVK Biosciences Private
  • Horizon Discovery Group
  • Selexis
  • Lonza
  • Abzena
  • Adimab

GLOBAL BIOLOGICS OUTSOURCING MARKET, BY PRODUCT TYPE

  • Antibody
  • Recombinant
  • Protein
  • Vaccines
  • Others

GLOBAL BIOLOGICS OUTSOURCING MARKET, BY APPLICATION

  • Therapeutics
  • Diagnostics
  • Research

GLOBAL BIOLOGICS OUTSOURCING MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

TABLE OF CONTENT

1. Biologics Outsourcing Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Biologics Outsourcing Market Snippet by Product Type
    • 2.1.2. Biologics Outsourcing Market Snippet by Application
    • 2.1.3. Biologics Outsourcing Market Snippet by Country
    • 2.1.4. Biologics Outsourcing Market Snippet by Region
  • 2.2. Competitive Insights

3. Biologics Outsourcing Key Market Trends

  • 3.1. Biologics Outsourcing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Biologics Outsourcing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Biologics Outsourcing Market Opportunities
  • 3.4. Biologics Outsourcing Market Future Trends

4. Biologics Outsourcing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Biologics Outsourcing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Biologics Outsourcing Market Landscape

  • 6.1. Biologics Outsourcing Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Biologics Outsourcing Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Antibody
    • 7.1.3. Recombinant
    • 7.1.4. Protein
    • 7.1.5. Vaccines
    • 7.1.6. Others

8. Biologics Outsourcing Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Therapeutics
    • 8.1.3. Diagnostics
    • 8.1.4. Research

9. Biologics Outsourcing Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Biologics Outsourcing Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Biologics Outsourcing Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Biologics Outsourcing Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Biologics Outsourcing Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Biologics Outsourcing Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Biologics Outsourcing Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Boehringer Ingelheim
    • 10.2.2. Catalent
    • 10.2.3. GenScript
    • 10.2.4. Innovent Biologics
    • 10.2.5. Syngene
    • 10.2.6. Shanghai Medicilon
    • 10.2.7. GL Biochem Corporation
    • 10.2.8. GVK Biosciences Private
    • 10.2.9. Horizon Discovery Group
    • 10.2.10. Selexis
    • 10.2.11. Lonza
    • 10.2.12. Abzena
    • 10.2.13. Adimab

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Biologics Outsourcing Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Biologics Outsourcing Market, by Product Type 2018-2030 (USD Million)
  • TABLE Biologics Outsourcing Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Biologics Outsourcing Market, by Application 2018-2030 (USD Million)
  • TABLE Biologics Outsourcing Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Biologics Outsourcing Market, by Region 2018-2030 (USD Million)
  • TABLE North America Biologics Outsourcing Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Biologics Outsourcing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Biologics Outsourcing Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Biologics Outsourcing Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Biologics Outsourcing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Biologics Outsourcing Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biologics Outsourcing Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biologics Outsourcing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biologics Outsourcing Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Biologics Outsourcing Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Biologics Outsourcing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Biologics Outsourcing Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biologics Outsourcing Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biologics Outsourcing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biologics Outsourcing Market, by Application, 2018-2030 (USD Million)